Literature DB >> 2203664

Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection.

N V Naoumov1, B C Portmann, R S Tedder, B Ferns, A L Eddleston, G J Alexander, R Williams.   

Abstract

The expression of hepatitis B virus antigens was studied by double staining liver tissue with appropriate antisera and correlated with serum hepatitis B viral DNA and histology in 28 patients with disease related to chronic hepatitis B virus infection. The cellular localization of hepatitis B core and hepatitis B e antigens generally coincided, but there were important differences at a subcellular level. Thus, hepatitis B e antigen was detected in nuclei and/or cytoplasm but strong cytoplasmic hepatitis B e antigen was associated with a high serum hepatitis B viral DNA (P = 0.0017) but not with active liver disease. Hepatitis B core antigen could also be detected in nuclei and/or cytoplasm, but strong cytoplasmic hepatitis B core antigen expression, exceeding that of hepatitis B e antigen, was associated with active liver disease (P = 0.041) and not with serum hepatitis B virus DNA. The proportion of hepatocytes expressing hepatitis B surface antigen correlated inversely with the serum titer (P = 0.0017), whereas hepatitis B surface and nucleocapsid antigens were usually expressed independently. The data support the hypothesis that cytoplasmic hepatitis B core antigen and not hepatitis B e antigen is the target for immune system-mediated cytolysis of hepatocytes. Cytoplasmic hepatitis B e antigen is not associated with liver damage but is instead associated with high levels of hepatitis B virus replication.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203664     DOI: 10.1016/0016-5085(90)90811-e

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

2.  RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.

Authors:  Christine I Wooddell; Man-Fung Yuen; Henry Lik-Yuen Chan; Robert G Gish; Stephen A Locarnini; Deborah Chavez; Carlo Ferrari; Bruce D Given; James Hamilton; Steven B Kanner; Ching-Lung Lai; Johnson Y N Lau; Thomas Schluep; Zhao Xu; Robert E Lanford; David L Lewis
Journal:  Sci Transl Med       Date:  2017-09-27       Impact factor: 17.956

3.  Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.

Authors:  Kei Fujiwara; Yasuhito Tanaka; Emma Paulon; Etsuro Orito; Masaya Sugiyama; Kiyoaki Ito; Ryuzo Ueda; Masashi Mizokami; Nikolai V Naoumov
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus.

Authors:  N V Naoumov; A L Eddleston
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

5.  Core antigen expression is associated with hepatic necroinflammation in e antigen-negative chronic hepatitis B patients with low DNA loads.

Authors:  Yi-Hsiang Huang; Hung-Hsu Hung; Che-Chang Chan; Chiung-Ru Lai; Chi-Jen Chu; Teh-Ia Huo; Pui-Ching Lee; Chien-Wei Su; Keng-Hsin Lan; Hui-Chun Huang; I-Cheng Lee; Han-Chieh Lin; Shou-Dong Lee
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

6.  HIV through the looking glass: insights derived from Hepatitis B.

Authors:  Maria M Rivera; Alejandro Soza; Alison Jazwinski; Lijun Mi; David E Kleiner; Xiongce Zhao; Charma Zuber; Douglas Brust; Emory Hsu; Jennifer Simpson; Jay H Hoofnagle; Theo Heller
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

7.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

8.  Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.

Authors:  M J Phillips; R Cameron; M A Flowers; L M Blendis; P D Greig; I Wanless; M Sherman; R Superina; B Langer; G A Levy
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

9.  Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Treatment of Hepatitis B e Antigen-negative Patients.

Authors:  Chee-Kin Hui; George K Lau
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.